Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03326921
Title HA-1 T TCR T Cell Immunotherapy for the Treating of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Fred Hutchinson Cancer Research Center
Indications

acute lymphoblastic leukemia

acute biphenotypic leukemia

juvenile myelomonocytic leukemia

chronic myeloid leukemia

acute myeloid leukemia

myelodysplastic syndrome

chronic myelomonocytic leukemia

Therapies

Fludarabine

HA-1 TCR T cells

Age Groups: senior | child
Covered Countries USA

Facility Status City State Zip Country Details
Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field